Has Amna Fareedy, MD received payments from drug or device companies?

Yes. Drug and device makers reported $560 in general payments to Amna Fareedy, MD across 23 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Amna Fareedy, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Amna Fareedy, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Amna Fareedy, MD

General Practice · Bakersfield, CANPI 1386177293

Payments from drug & device makers

$560in general payments, 2019–2025

Across 23 payments — averaging $24.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Johnson & Johnson$338
AstraZeneca$39
Novartis$37
W. L. Gore & Associates, Inc.$36
Pfizer$23
Philips North America LLC$21
plus $67 from 4 others

What the payments were for

Food & beverage$560100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Johnson & Johnson	12	$338
AstraZeneca(2 entities)	2	$39
Novartis	2	$37
W. L. Gore & Associates, Inc.	1	$36
Pfizer	1	$23
Philips North America LLC	1	$21
Gilead	1	$20
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)	1	$18
GSK	1	$16
E.r. Squibb & Sons, L.L.C.	1	$12

How this compares

$560 in reported general payments places this provider in the 70th percentile of 12,963 general practice providers in California.

See all general practice providers in California →

Medicare billing

Part B allowed, 2024

$140,164

Medicare patients

363

Services billed

1,366

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Metoprolol Succinate	35	$304
Pantoprazole Sodium	36	$296
Atorvastatin Calcium	30	$257
Torsemide	16	$236
Amlodipine Besylate	24	$144
Cefdinir	13	$131
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav	18	$116
ClopidogrelClopidogrel Bisulfate	12	$97
Spironolactone	17	$94
Oxycodone Hcl	21	$94
Metoprolol Tartrate	12	$53
Ciprofloxacin Hcl	11	$42
Furosemide	11	$32
Prednisone	15	$25

Paid to pharmacies, not to this prescriber.

Other general practice in Bakersfield

Hessam AazamiCanoga Park$88.4M
Frederic MollRedwood City$5.7M
Nathan LiLancaster$5.2M
Milton McCollSan Jose$4.9M
Bruce TorkanLos Angeles$3.8M
Daniel JohnsonPalm Desert$1.5M
Bradley ChingUpland$1.4M
Jared AdamsSan Francisco$862K
Marina GoldGlendale$784K
Eric BrassTorrance$755K

See the full list for California →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →